Cargando…
Simple rapid in vitro screening method for SARS-CoV-2 anti-virals that identifies potential cytomorbidity-associated false positives
BACKGROUND: The international SARS-CoV-2 pandemic has resulted in an urgent need to identify new anti-viral drugs for treatment of COVID-19. The initial step to identifying potential candidates usually involves in vitro screening that includes standard cytotoxicity controls. Under-appreciated is tha...
Autores principales: | Yan, Kexin, Rawle, Daniel J., Le, Thuy T., Suhrbier, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188739/ https://www.ncbi.nlm.nih.gov/pubmed/34107996 http://dx.doi.org/10.1186/s12985-021-01587-z |
Ejemplares similares
-
Evolution of ACE2-independent SARS-CoV-2 infection and mouse adaption after passage in cells expressing human and mouse ACE2
por: Yan, Kexin, et al.
Publicado: (2022) -
Pathophysiological Response to SARS-CoV-2 Infection Detected by Infrared Spectroscopy Enables Rapid and Robust Saliva Screening for COVID-19
por: Kazmer, Seth T., et al.
Publicado: (2022) -
Detection of SARS-COV N2 Gene: Very low amounts of viral RNA or false positive?
por: Falasca, Francesca, et al.
Publicado: (2020) -
Warmer ambient air temperatures reduce nasal turbinate and brain infection, but increase lung inflammation in the K18-hACE2 mouse model of COVID-19
por: Dumenil, Troy, et al.
Publicado: (2023) -
Widespread discrepancy in Nnt genotypes and genetic backgrounds complicates granzyme A and other knockout mouse studies
por: Rawle, Daniel J, et al.
Publicado: (2022)